Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition
- PMID: 31951560
- DOI: 10.1016/j.ccell.2019.12.008
Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition
Abstract
Therapeutic resistance is a major challenge in cancer treatment. In this issue of Cancer Cell, Kurppa et al. demonstrated that a senescence-like state enables lung cancer cells to survive dual inhibition of EGFR and MEK. This was mediated by the YAP/TEAD pathway, which drives epigenomic reprogramming and EMT to counteract apoptosis.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment on
-
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.Cancer Cell. 2020 Jan 13;37(1):104-122.e12. doi: 10.1016/j.ccell.2019.12.006. Cancer Cell. 2020. PMID: 31935369 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous